Short answer
Medpace Holdings Inc (MEDP) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 and first-half 2026 financial results announced for periods ended June 30, 2026.
Medpace Holdings Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 and first-half 2026 financial results announced for periods ended June 30, 2026
- Full earnings release available in Exhibit 99.1, containing the detailed operating and financial results
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $707.3M, up 17.2%, with backlog conversion rate 24.1%
- Net new awards $795.7M, up 28.2%, producing 1.13x book-to-bill and supporting future revenue
- Backlog $3,014.2M, up 4.9%, indicating continued demand despite slower backlog growth than bookings
- GAAP EPS $4.25, up from $3.10, while net margin expanded to 17.2% from 15.0%
- FY2026 guidance: revenue $2.805B-$2.885B, EBITDA $618M-$642M, diluted EPS $17.25-$17.95; $294.7M spent repurchasing 705,616 shares
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Medpace Holdings Inc 8-K filings
Get the next MEDP 8-K as it lands
Follow MEDP for push alerts, or ask the research agent what this filing means.